An Associated Press analysis of FDA records found that government inspectors have not returned to nearly 2,000 factories due for a safety surveillance inspection. (AP Video: Shelby Lum; Mary Conlon; Ajit Solanki. Production: Shelby Lum)
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds
An Associated Press analysis of FDA records found that government inspectors have not returned to nearly 2,000 factories due for a safety surveillance inspection. (AP Video: Shelby Lum; Mary Conlon; Ajit Solanki. Production: Shelby Lum)